Recombinant alpha-galactosidase (Eleva GmbH)

N/A

Report date: 2024/06/12 11:59:24

Base Information

Drug NameRecombinant alpha-galactosidase (Eleva GmbH)
Drug Alias NameRepleva aGALRecombinant aGalRPV-001
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of Actionα-Galactosidase replacements
Targetsα-Galactosidase
Therapy Area/IndicationsFabry Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEleva GmbH
China Registration ClassN/A

Develop Information

Active CompaniesEleva GmbH
Inactive CompaniesN/A
Active IndicationsFabry Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A